According to the low predictive values of ALT, GGT and ultrasonography, as well as the risk and the variability of liver biopsy, the previous strategy could be improved by using better biomarkers of steatosis, such as ST, combined with biomarkers of fibrosis, such as FibroTest-Fibrosure, and with biomarkers of steatohepatitis. Here, GPT is linked to steatosis.